Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06134596
Other study ID # 2023-06-06
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date November 1, 2023
Est. completion date March 1, 2024

Study information

Verified date November 2023
Source Bagcilar Training and Research Hospital
Contact Evrim Ebru Kovalak, MD
Phone 905324628989
Email evrimebru@yahoo.com
Is FDA regulated No
Health authority
Study type Observational [Patient Registry]

Clinical Trial Summary

To evaluate the relationship between women's labium minora and clitoral hood measurements and Female Genital Self Image Scale (FGSIS) scores.


Description:

The main purpose of our study is to measure the labium minora and clitoral hood in women who apply to our clinic with gynecological disorders, evaluate them with FGSIS (Female Genital Self Image Scale) scores, and look at the relationship between genital area perception and labium minora and clitoral hood dimensions.


Recruitment information / eligibility

Status Recruiting
Enrollment 200
Est. completion date March 1, 2024
Est. primary completion date December 31, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender Female
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Women who apply for outpatient gynecological control, are between the ages of 18-45, are sexually active, do not have additional endocrinological or malignant diseases, and are not pregnant or in menopause. Exclusion Criteria: - Those who are not sexually active, have varying degrees of pelvic organ prolapse or urinary incontinence, have a malignancy, or have an endocrinological disease

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Turkey Bagcilar Teaching and Research Hospital Istanbul Bagcilar

Sponsors (1)

Lead Sponsor Collaborator
Bagcilar Training and Research Hospital

Country where clinical trial is conducted

Turkey, 

References & Publications (1)

Widschwendter A, Riedl D, Freidhager K, Abdel Azim S, Jerabek-Klestil S, D'Costa E, Fessler S, Ciresa-Konig A, Marth C, Bottcher B. Perception of Labial Size and Objective Measurements-Is There a Correlation? A Cross-Sectional Study in a Cohort Not Seekin — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Correlation of genital measurement with genital perception Since the genital aesthetic trend is very popular today, it is important to understand the importance of labia minora and clitoral hood measurements in female genital perception. 2 months
See also
  Status Clinical Trial Phase
Recruiting NCT04566952 - Anlotinib Combined With Dose-reduced Olaparib in Patients With Platinum-Sensitive Recurrent Ovarian Cancer Phase 2
Completed NCT03562897 - Evaluation of Ocoxin-Viusid® in Advanced or Metastatic Ovarian Epithelial Cancer Phase 2
Completed NCT01456962 - Influence of Antiretroviral Regimen on Immune Reconstitution in the Female Genital Tract N/A
Completed NCT01460979 - Efficacy,Tolerability,Safety of Temsirolimus in Women With Platinum-refractory Ovarian Carcinoma or Advanced Endometrial Carcinoma Phase 2
Completed NCT00050414 - A Study of Trabectedin in Patients With Advanced Ovarian Cancer Phase 2
Completed NCT01526668 - Follow-up Strategies for Improved Postoperative Recovery After Benign Hysterectomy N/A
Recruiting NCT04556071 - Efficacy and Safety of Niraparib Combined With Bevacizumab in Platinum Refractory/Resistant Recurrent Ovarian Cancer Phase 2
Completed NCT01462890 - Evaluation of Optimal Treatment Duration of Bevacizumab Combination With Standard Chemotherapy in Patients With Ovarian Cancer Phase 3
Completed NCT01523652 - Pharmacokinetic Study on the Administration of Nadroparin Dosing Serum HGF in Gynecological Patients N/A
Completed NCT02747641 - Prospective, Open-Label, Single-Center, Non-Comparative Study to Assess the Use of Pixel CO2 Laser System (FemiLift) in the Treatment of Vulvovaginal Atrophy (VVA) in Postmenopausal Female Subjects N/A
Completed NCT00365716 - Dose-Ranging Study of Quadrivalent Human Papillomavirus (HPV) (Types 6,11,16,18) L1 Virus-Like Particle (VLP) Vaccine (V501-007)(COMPLETED) Phase 2
Completed NCT03677336 - Oral Dydrogesterone (OD) Versus Micronized Vaginal Progesterone (MVP) for Luteal Phase Support (LPS) in IVF/ICSI Phase 4
Completed NCT02698527 - The Effect of Buffered Lidocaine Versus Nonbuffered Lidocaine on Pain Scores During Infiltration for Vulvar Biopsies N/A
Not yet recruiting NCT04807166 - Anlotinib Combined With Carboplatin/Paclitaxel as First-line Treatment in Patients With Advanced Ovarian Cancer Phase 2
Completed NCT04858919 - Transrectal and 3D Transabdominal Ultrasound Compared to Vaginoscopy in Diagnosing Virgins With Genital Lesions N/A
Completed NCT01628432 - Effect of Salpingectomy During Conservative Hysterectomy N/A
Active, not recruiting NCT01271400 - LANDA Embryo Freezing Technique. N/A
Completed NCT02642835 - A Long Term Follow up of Anterior Meshes for Recurrent Prolapse
Recruiting NCT04061967 - SMS-based Summons in Cervical Screening N/A
Completed NCT04746053 - Ovarian Function and Gynecological Profile of Patients Carrying a Pathogenic Variant of the HNF1B Gene (GYN-HNF1) N/A